Press Release No. 20
Berlin
Cancer-fighting gene therapy: from research to application
Whether repairing faulty genes or introducing characteristics by delivering new genes into cells, gene therapy holds great potential for personalized medicine. However, safe, efficient and cost-effective therapies of this kind are currently few and far between for clinical use. Researchers at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) now want to translate a new cancer therapy involving reprogrammed immune cells from the laboratory scale to the clinic, and are cooperating with industry partners to achieve this. The Helmholtz Association is supporting the transfer process by setting up a Helmholtz Innovation Lab at the MDC.